1.
Vohra SR, Ravichandran S, Foard D, Martinez-Naharro A, Venneri L, Fontana M, Whelan CJ, Hawkins PN, Gillmore J, Lachmann HJ, Mahmood S, Wechalekar AD. A retrospective study of isatuximab-pomalidomidedexamethasone in relapsed/refractory systemic AL amyloidosis. haematol [Internet]. 2025Dec.1 [cited 2025Dec.5];110(12):3109-13. Available from: https://haematologica.org/article/view/12153